ArticleJournal of breast cancer2014

Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer.

Potjana Jitawatanarat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.